Nosocomial Norovirus Outbreak Associated with Persistent Norovirus Excretion in a Patient Receiving Corticosteroid Therapy

  • NAGASAKI Naho
    Department of Medical Safety Management, Kagoshima Prefectural Satsunan Hospital
  • TANAKA Hiroyuki
    Department of General Internal Medicine, Kagoshima Prefectural Satsunan Hospital
  • TOKUDA Koichi
    Department of Infection Control, Tohoku University Hospital
  • KAWAMURA Hideki
    Department of Infection Control, Kagoshima University Hospital
  • KODAMA Yuichi
    Department of Infection Control, Kagoshima University Hospital
  • IMUTA Naoko
    Department of Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences
  • NISHI Junichiro
    Department of Infection Control, Kagoshima University Hospital Department of Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences

Bibliographic Information

Other Title
  • ステロイド使用患者の持続ウイルス排泄が伝播に関連したと考えられるノロウイルス胃腸炎集団発生事例

Search this article

Abstract

<p>Although chronic norovirus infection has been reported in immunocompromized patients receiving chemotherapy or undergoing transplantation, there have been few reports of nosocomial norovirus outbreaks associated with persistent norovirus excretion in a patient receiving corticosteroid therapy. In a medical ward with several patients receiving corticosteroid therapy, an outbreak of norovirus gastroenterocolitis was observed in four patients and one healthcare worker. Two of the four patients shared a room with an asymptomatic patient with idiopathic interstitial pneumonia who was receiving corticosteroid therapy and who had been admitted with norovirus infection 23 days ago. Norovirus sugar-chain-immobilized gold nanoparticle (SGNP) reverse-transcription (RT) quantitative PCR (qPCR) demonstrated the presence of infectious norovirus virions in the patient's stool 35 days after the onset of diarrhea. Thus, the patient was assumed to have excreted norovirus while sharing a room with the two patients who developed norovirus gastroenterocolitis; this suggested that the patient's prolonged excretion of norovirus triggered the outbreak. In addition, norovirus SGNP-RT-qPCR tests of other patients receiving corticosteroid therapy yielded positive results 10 days after the onset. Considering the course of this outbreak, a longer than usual isolation period may be required for norovirus gastroenterocolitis patients receiving corticosteroid therapy. Norovirus SGNP-RT-qPCR tests may be useful in determining the isolation period required for immunocompromised patients with norovirus gastroenterocolitis in the setting of high-risk wards for norovirus infection.</p>

Journal

References(7)*help

See more

Details 詳細情報について

Report a problem

Back to top